Structure–Activity Relationship Studies of 3-Aroylindoles as Potent Antimitotic Agents-Reference-Cited by-同舟云学术

Structure–Activity Relationship Studies of 3-Aroylindoles as Potent Antimitotic Agents

Published:2006-10-13 Issue:10 Volume:1 Page:1106-1118
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Liou Jing-Ping,Mahindroo Neeraj,Chang Chun-Wei,Guo Fu-Ming,Lee Sandy Wen-Hsing,Tan Uan-Kang,Yeh Teng-Kuang,Kuo Ching-Chuan,Chang Yi-Wei,Lu Ping-Hsun,Tung Yen-Shih,Lin Ke-Ta,Chang Jang-Yang,Hsieh Hsing-Pang

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference19 articles.

1. Antitubulin agents for the treatment of cancer – a medicinal chemistry update

2. Discovery and development of antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer

3. Recent advances in the field of tubulin polymerization inhibitors

4. Modulation of oral bioavailability of anticancer drugs: from mouse to man

5. Clinical pharmacology of anticancer agents in relation to formulations and administration routes

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress in Free Radical Transformations of Allenamides;Current Organic Synthesis;2024-11

2. Omega-3 fatty acids for uremic pruritus: A meta-analysis of randomized controlled trials;Tzu Chi Medical Journal;2022

3. Further Developments on the Regioselective Synthesis of 3-Aroylindole Derivatives from <i>C</i>-Nitrosoaromatics and Alkynones: A Novel Synthetic Approach to Pravadoline, JWH-073, Indothiazinone Analogues and Related Compounds;International Journal of Organic Chemistry;2022

4. Allenamides Playing Domino: A Redox‐Neutral Photocatalytic Synthesis of Functionalized 2‐Aminofurans;Advanced Synthesis & Catalysis;2021-10-18

5. Structural Investigations of Aroylindole Derivatives through 3D-QSAR and Multiple Pharmacophore Modeling for the Search of Novel Colchicines Inhibitor;Letters in Drug Design & Discovery;2021-04-07